TEMPO.CO, Jakarta - PT Kimia Farma Tbk posted a current-year loss of Rp234.1 billion from January to September 2025. This figure is down from Rp550.8 billion in the same period last year. According to ...

TEMPO.CO, Jakarta - Secretary General of the Federation of State-Owned Enterprise Workers, Indonesia Raya, Ridwan Kamil, is urging the Investment Management Agency of Anagata Nusantara (Danantara), as ...

In Chengdu, China, the Indonesia-China Healthcare & Biotech Investment Forum was jointly held by Indonesian Chamber of Commerce and Industry Bilateral Committee for China (KIKT) and Embassy of the ...

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed! ndonesia’s biggest ...

Kimia Farma Persero has a price-to-earnings (P/E) ratio of -5 (TTM). This compares to an industry average of 22. What is Kimia Farma Persero’s price-to-sales ratio? The P/S ratio for Kimia Farma ...

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed! imia Farma Apotek, a ...

Kimia Farma Persero (KAEF) has delivered a -10% change over the past year, with a 52-week range between 324 and 765. What Is the Average Daily Trading Volume of Kimia Farma Persero (KAEF)? The average ...

Find the latest PT Kimia Farma Tbk (KAEF.JK) stock quote, history, news and other vital information to help you with your stock trading and investing.

Kimia Farma, which is owned by the Indonesian government, and South Korea’s SungWun Pharmacopia are teaming up to build a $10.2 million API facility expected to begin operations in 2018. The ...